Gyrus Capital closes €700 million continuation vehicle for Essential Pharma

Essential is a specialty pharma group.

1 May 2025•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.